...
首页> 外文期刊>BMC Cancer >Role of geriatric intervention in the treatment of older patients with cancer: rationale and design of a phase III multicenter trial
【24h】

Role of geriatric intervention in the treatment of older patients with cancer: rationale and design of a phase III multicenter trial

机译:老年医学干预在老年癌症患者治疗中的作用:III期多中心试验的原理和设计

获取原文
           

摘要

Background In the general geriatric population, programs linking geriatric evaluation with interventions are effective for improving functional status and survival of the patients. Whether or not these interventions improve health related quality of life (HRQoL) or overall survival (OS) in older patients with cancer is not yet clear. Indeed, randomized data on the effect of such interventions on survival and HRQoL are rare and conflicting. We describe the rationale and design of a phase III multicenter trial aimed at assessing the efficacy of geriatric intervention in the management of elderly patients with cancer. Methods/design Approximately 1200 patients, 70?years and older, considered in need of a geriatric intervention based on the G8 screening tool will be randomized into two intervention arms. The ‘Usual-care’ arm involves standard oncological care based on pre-defined oncological protocols. In addition to the standard oncological care, the ‘Case-management’ arm involves a multidimensional geriatric assessment and interventions tailored for the patient. Efficacy will be assessed using a co-primary endpoint encompassing OS and HRQoL. Discussion This trial has been designed to assess whether focused geriatric case management can either improve OS or HRQoL in elderly cancer patients considered in need of geriatric assessment. Trial registration Clinicaltrials.gov ID: NCT02704832 .
机译:背景技术在普通的老年人群中,将老年医学评估与干预措施联系起来的程序可有效改善患者的功能状态和存活率。这些干预措施是否能够改善老年癌症患者的健康相关生活质量(HRQoL)或总体生存率(OS),目前尚不清楚。实际上,关于此类干预措施对生存率和HRQoL的影响的随机数据很少,而且相互矛盾。我们描述了旨在评估老年干预治疗老年癌症患者疗效的III期多中心试验的原理和设计。方法/设计根据G8筛查工具,大约1200名70岁及以上的老年患者被认为需要老年医学干预,将被随机分为两个干预组。 “常规护理”部门涉及基于预先定义的肿瘤学方案的标准肿瘤学护理。除了标准的肿瘤治疗外,“病例管理”部门还包括针对患者的多维老年医学评估和干预措施。将使用包括OS和HRQoL在内的共同主要终点来评估疗效。讨论本试验旨在评估老年患者的重点病例管理是否可以改善需要老年评估的老年癌症患者的OS或HRQoL。试用注册Clinicaltrials.gov ID:NCT02704832。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号